WBI Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-63,552
Closed -$946K – 308
2025
Q1
$946K Buy
+63,552
New +$977K 0.25% 103
2024
Q3
– Sell
-46,869
Closed -$970K – 259
2024
Q2
$970K Sell
46,869
-75,369
-62% -$1.5M 0.24% 97
2024
Q1
$2.3M Buy
122,238
+60,271
+97% +$1.03M 0.48% 50
2023
Q4
$894K Buy
61,967
+1,779
+3% +$24.2K 0.18% 121
2023
Q3
$1.04M Buy
+60,188
New +$1.26M 0.21% 112

Other funds holding OGN

WBI Investments's OGN Position: Q2 2025 in Review

WBI Investments sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 63,552 shares — an estimated $946K sold.

WBI Investments first reported a position in OGN in Q3 2023 and held it in 5 quarters. The position peaked at $2.3M in Q1 2024. 696 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • WBI Investments reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • WBI Investments sold 63,552 Organon & Co shares in Q2 2025, an estimated $946K.
  • WBI Investments first reported a position in Organon & Co in Q3 2023 and held it in 5 quarters.
  • WBI Investments's Organon & Co position peaked at $2.3M in Q1 2024.
  • 696 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on WBI Investments's 13F filing for Q2 2025, filed 11 Aug 2025.